WI
ABBV icon

Wedgewood Investors’s AbbVie ABBV Stock Holding History

Wedgewood Investors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$370K Hold
1,700
– – 0.42% 62
2025
Q4 		$388K Hold
1,700
– – 0.44% 59
2025
Q3 		$394K Sell
1,700
-202
-11% -$41.1K 0.43% 59
2025
Q2 		$353K Sell
1,902
-270
-12% -$50.2K 0.41% 60
2025
Q1 		$455K Buy
+2,172
New +$422K 0.54% 46
2024
Q4 		– Sell
-2,232
Closed -$441K – 97
2024
Q3 		$441K Hold
2,232
– – 0.48% 56
2024
Q2 		$383K Buy
+2,232
New +$370K 0.45% 63
2023
Q4 		$346K Hold
2,232
– – 0.43% 64
2023
Q3 		$333K Hold
2,232
– – 0.45% 64
2023
Q2 		$301K Hold
2,232
– – 0.39% 73
2023
Q1 		$356K Sell
2,232
-200
-8% -$30.6K 0.47% 64
2022
Q4 		$393K Buy
+2,432
New +$373K 0.52% 59

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wedgewood Investors's ABBV Position: Q1 2026 in Review

Wedgewood Investors held its AbbVie (ABBV) position steady in Q1 2026 at 1,700 shares worth $370K. The position accounts for 0.42% of the portfolio, ranked #62.

Wedgewood Investors first reported a position in ABBV in Q4 2022 and has held it in 12 quarters since. The position peaked at $455K in Q1 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Wedgewood Investors held 1,700 shares of AbbVie worth $370K as of Q1 2026.
  • Wedgewood Investors left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.42% of Wedgewood Investors's portfolio in Q1 2026, its #62 holding.
  • Wedgewood Investors first reported a position in AbbVie in Q4 2022 and has held it in 12 quarters since.
  • Wedgewood Investors's AbbVie position peaked at $455K in Q1 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Wedgewood Investors's 13F filing for Q1 2026, filed 5 May 2026.